These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. Wojcik S Folia Histochem Cytobiol; 2013; 51(4):249-64. PubMed ID: 24497130 [TBL] [Abstract][Full Text] [Related]
7. Proteasome Inhibitors in Cancer Therapy and their Relation to Redox Regulation. Sari G; Okat Z; Sahin A; Karademir B Curr Pharm Des; 2018; 24(44):5252-5267. PubMed ID: 30706779 [TBL] [Abstract][Full Text] [Related]
8. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy. Tsukamoto S Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439 [TBL] [Abstract][Full Text] [Related]
9. Recent Patents on Proteasome Inhibitors of Natural Origin. da Silva DC; Andrade PB; Ribeiro V; Valentao P; Pereira DM Recent Pat Anticancer Drug Discov; 2017; 12(1):4-15. PubMed ID: 27881056 [TBL] [Abstract][Full Text] [Related]
10. Discovery and development of second-generation proteasome inhibitors. Kirk CJ Semin Hematol; 2012 Jul; 49(3):207-14. PubMed ID: 22726543 [TBL] [Abstract][Full Text] [Related]
11. Novel proteasome inhibitors to overcome bortezomib resistance. Ruschak AM; Slassi M; Kay LE; Schimmer AD J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441 [TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition: a new therapeutic strategy to cancer treatment. Wu WK; Cho CH; Lee CW; Wu K; Fan D; Yu J; Sung JJ Cancer Lett; 2010 Jul; 293(1):15-22. PubMed ID: 20133049 [TBL] [Abstract][Full Text] [Related]
13. Oxidative protein damage and the proteasome. Grimm S; Höhn A; Grune T Amino Acids; 2012 Jan; 42(1):23-38. PubMed ID: 20556625 [TBL] [Abstract][Full Text] [Related]
14. [Development and clinical application of novel proteasome inhibitors]. Iida S Rinsho Ketsueki; 2012 Apr; 53(4):417-25. PubMed ID: 22687975 [No Abstract] [Full Text] [Related]
15. The nuclear proteasome and the degradation of oxidatively damaged proteins. Voss P; Grune T Amino Acids; 2007; 32(4):527-34. PubMed ID: 17103119 [TBL] [Abstract][Full Text] [Related]
18. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Jarvius M; Fryknäs M; D'Arcy P; Sun C; Rickardson L; Gullbo J; Haglund C; Nygren P; Linder S; Larsson R Biochem Biophys Res Commun; 2013 Feb; 431(2):117-23. PubMed ID: 23318177 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors in cancer therapy: a novel approach to a ubiquitous problem. Landis-Piwowar KR Clin Lab Sci; 2012; 25(1):38-44. PubMed ID: 22458048 [TBL] [Abstract][Full Text] [Related]
20. Feedback regulation of proteasome gene expression and its implications in cancer therapy. Xie Y Cancer Metastasis Rev; 2010 Dec; 29(4):687-93. PubMed ID: 20835843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]